Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1362855B1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1304324B1 Serotonin reuptake inhibitors
10/03/2007EP1244458B1 Weight promoting composition, method, and product
10/03/2007EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions
10/03/2007EP0735896B1 Parathyroid hormone formulation
10/03/2007CN101048402A Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
10/03/2007CN101048382A New indole or benzimidazole derivatives
10/03/2007CN101048367A New tyrosine derivative as ppar gamma regulator
10/03/2007CN101048166A Abnormal protein removing composition
10/03/2007CN101048153A Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions
10/03/2007CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3
10/03/2007CN101045166A Pulmonary administration of chemically modified insulin
10/03/2007CN101045158A Insulin analog dry powder composition and its preparing method
10/03/2007CN101045140A Oral liquor with functions of lower blood sugar, lowering blood pressure and relaxing the bowels
10/03/2007CN101045111A Inhibitor of fatty-acid synthase its preparing method and application
10/03/2007CN101045088A Medicine composition for treating diabetes and its preparing method
10/03/2007CN101045077A Preparating method of oral solid preparation of fenugreek and its use
10/03/2007CN101045076A Extractive of persimmon leaves ethyl acetate used for prevention and/or treatment of glycolipid metabolism related diseases
10/03/2007CN101045055A Pipecolic acid-containing antidiabetic compositions
10/03/2007CN101045052A Medicine composition for treating cardiovascular disease
10/03/2007CN101045048A Application of chondriosome nutrient composition for preventing and treating insulin resistance and biabetes
10/03/2007CN101045044A Thipronin enteric-coated delayed-release agent
10/03/2007CN101045039A Dosage form for treatment of diabetes mellitus
10/03/2007CN101044910A Seaweed health-care food and its preparing method
10/03/2007CN101044902A Health-care product for reducing weight and lowering cholesterin content in blood
10/03/2007CN101044899A Health-care beverage containing ginger amino-acid
10/03/2007CN101044888A Method for producing dried noodles containing tu-chung and haw rich in naturla active substances
10/03/2007CN101044886A Premixed feed used specially for milk cow before perinatal period and its producing method
10/03/2007CN101044879A Method for producing tea of loquat flower petals
10/03/2007CN101044877A Weight-reducing tea
10/03/2007CN101044874A Ginseng and milk beverage and its preparing method
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340279C Anredera cordifolia(Ten.)Sreenis electuary and its preparation method
10/03/2007CN100340271C Hypoglycemic medicine for treating diabetes and its prepn process
10/03/2007CN100340264C Pharmaceutical composition for treating hypertension and hyperlipemia and its preparation method
10/03/2007CN100340260C Method for preparing blood sugar-decreasing sleep-assisting intestine-benefiting oral liquid with micron mulberry leaf, hawthorn fruit, amber, pseudostellaria root and royal jelly
10/03/2007CN100340259C Method for preparing blood sugar-decreasing sleep-assisting intestine-benefiting capsule and powder with micron mulberry leaf, hawthorn fruit, amber, asiabell, royal jelly
10/03/2007CN100340250C Composite propolis soft capsule
10/03/2007CN100340248C Blood sugar and blood lipoid reducing products prepared by use of coprinus and production method thereof
10/03/2007CN100340247C Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite
10/03/2007CN100340242C Remedies for diabetes
10/02/2007US7277534 Communications system and method
10/02/2007US7276610 Aryl piperidine amides
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276539 In which the phenyl group is p-substituted with a 2-(p-(methylsulfonyloxy)phenoxy)ethyl group; used for treating type 2 diabetes and dyslipidemia; may be combined with atorvastatin, rosuvastatin, or an IBAT inhibitor.
10/02/2007US7276538 Composition and a method for treating hair loss
10/02/2007US7276533 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
10/02/2007US7276527 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
10/02/2007US7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
10/02/2007US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic
10/02/2007US7276505 Immunomodulating heterocyclic compounds
10/02/2007US7276504 Nasally administering an imidazotriazinone substituted with an (alkoxy)(aminosulfonyl)phenyl group for treating diseases including psoriasis, female infertility, diabetes, glaucoma, cystic fibrosis, pre-eclampsia, Parkinsonism, tinnitus, pain, gastric motility disorders, and pulmonary hypertension
10/02/2007US7276503 Administration of optically pure (S,S) reboxetine, or a salt thereof; diminished adverse side effects
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276342 Reduce body mass; obesity therapy; hyperlipemia; insulin resistance; atherosclerosis; antidiabetic agents; hypotensive agents
10/02/2007CA2532332C Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics
10/02/2007CA2412564C Purine derivatives
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2309027C Method for treating hypercholesterolemia with unsubstituted polydiallylamine
10/02/2007CA2296653C Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
09/2007
09/27/2007WO2007109088A2 Combinationtherapies of thiazolidinedione analogues and glucocorticoid agonists
09/27/2007WO2007109037A2 Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
09/27/2007WO2007109024A2 Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
09/27/2007WO2007108744A2 Novel quinazolines as 5-ht6 modulators
09/27/2007WO2007108743A2 Novel quinazolines as 5-ht6 modulators ii
09/27/2007WO2007108727A1 Method for monitoring the effect of compounds on foxc2 expression
09/27/2007WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007WO2007108530A1 Muscle fatigue remedy
09/27/2007WO2007108009A1 A process for purification of topiramate
09/27/2007WO2007107869A2 Lipid derivatives
09/27/2007WO2007107550A1 Adamantane derivatives for the treatment of the metabolic syndrome
09/27/2007WO2007107373A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/27/2007WO2007107354A1 Rosiglitazone hydrochloride hemihydrate
09/27/2007WO2007107008A1 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
09/27/2007WO2007092755A3 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
09/27/2007WO2007092086A3 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
09/27/2007WO2007092065A9 Compounds and compositions as lxr modulators
09/27/2007WO2007059955A3 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
09/27/2007WO2006105850A8 Acyl hydrazides as kinase inhibitors, in particular for sgk
09/27/2007WO2006076317A9 Aminophenyl derivatives as selective androgen receptor modulators
09/27/2007US20070225359 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225349 Substituted 4-(Indazol-3-yl)phenols
09/27/2007US20070225308 2-Amino Quinazoline Derivative
09/27/2007US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/27/2007US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2
09/27/2007US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases
09/27/2007US20070224649 Novel scavenger receptor
09/27/2007US20070224265 Tablet Comprising Branched Chain Amino Acid and Method for Producing the Same
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/27/2007US20070224214 Composition Exerting Physiological Activity Via Biological Immune Mechanism
09/27/2007DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1298